Insulin Dosing Adjustment for Dexamethasone-Induced Hyperglycemia
For this 120 kg patient transitioning from dexamethasone 10 mg q6h to q8h, increase the 10 am NPH dose to 40-45 units, maintain the 8 pm NPH dose at 30-35 units, adjust ISF to 1:30, and set ICR to 1:8.
Current Clinical Assessment
Your patient demonstrates inadequate glycemic control with persistent hyperglycemia (BG 233→270→317→255 mg/dL) despite receiving NPH 30 units at 10 am and 25 units at 8 pm. The current ISF of 1:20 and ICR of 1:6 are insufficient for this degree of steroid-induced insulin resistance.
Rationale for Dexamethasone Schedule Change
Changing from q6h to q8h dosing reduces the total daily dexamethasone from 40 mg to 30 mg daily—a 25% reduction in steroid burden. However, dexamethasone has a prolonged duration of action (36-72 hours) with sustained hyperglycemic effects throughout the day and night, requiring NPH administered twice daily 1.
NPH Dose Calculations
Morning (10 am) NPH Dose
The guideline-recommended approach for dexamethasone-induced hyperglycemia is 0.1-0.4 units/kg per 10 mg prednisone equivalent dose 1. Dexamethasone 10 mg equals approximately 67 mg prednisone equivalent (conversion factor 6.7).
For 30 mg daily dexamethasone (≈200 mg prednisone equivalent):
- Weight-based calculation: 0.2-0.3 units/kg × 120 kg = 24-36 units base dose
- Steroid-adjusted: Add 0.2 units/kg per 10 mg prednisone equivalent = 0.2 × 120 × 20 = additional 4.8 units per 100 mg prednisone
- Target morning NPH: 40-45 units (accounting for demonstrated insulin resistance and current hyperglycemia)
Evening (8 pm) NPH Dose
Administer NPH twice daily for dexamethasone 1. The evening dose should be approximately 60-70% of the morning dose to match dexamethasone's pharmacodynamics:
- Target evening NPH: 30-35 units
This represents an increase from your current 25 units, as the patient's overnight glucose (255 mg/dL at 0200) indicates inadequate overnight coverage.
Correction Insulin Parameters
Insulin Sensitivity Factor (ISF)
Current ISF of 1:20 is inadequate. The guideline recommends ISF 1:25-1:30 for steroid-induced hyperglycemia 1. Given this patient's demonstrated insulin resistance:
- New ISF: 1:30 (1 unit lowers BG by 30 mg/dL)
- Target BG: 150 mg/dL for correction calculations
Insulin-to-Carbohydrate Ratio (ICR)
Current ICR of 1:6 is too aggressive for this degree of insulin resistance. Adjust to:
- New ICR: 1:8 (1 unit per 8 grams carbohydrate)
- This accounts for steroid-induced insulin resistance while avoiding excessive prandial dosing
Complete Insulin Regimen
Morning (10 am with dexamethasone):
- NPH: 40-45 units subcutaneously
- Correction insulin using ISF 1:30 if BG >150 mg/dL
- Prandial insulin using ICR 1:8 if eating
Evening (8 pm):
- NPH: 30-35 units subcutaneously
- Correction insulin using ISF 1:30 if BG >150 mg/dL
- Prandial insulin using ICR 1:8 if eating
Other meal times:
- Prandial insulin using ICR 1:8
- Correction insulin using ISF 1:30 if BG >150 mg/dL
Monitoring and Titration
- Check BG before meals and at bedtime (minimum 4 times daily)
- Increase NPH doses by 10% daily until fasting and pre-dinner BG targets <150 mg/dL are achieved 1
- If hypoglycemia occurs (BG <70 mg/dL), reduce corresponding NPH dose by 10-20% 2
- Monitor for hypoglycemia risk, particularly overnight with the increased evening NPH dose
Critical Considerations
The evidence demonstrates that steroid-induced hyperglycemia is consistently undertreated with initial insulin dosing 1. Studies show that more aggressive initial NPH dosing (0.5 units/mg prednisone equivalent) achieves better glycemic control without increased hypoglycemia 3, 4. Your patient's persistent hyperglycemia despite current therapy confirms inadequate dosing.
When dexamethasone is discontinued, insulin requirements will drop precipitously within 24-48 hours—reduce NPH doses by 50% immediately and monitor closely for hypoglycemia 5.
The twice-daily NPH regimen specifically matches dexamethasone's prolonged hyperglycemic effect better than once-daily long-acting insulin 1, 6. Research shows that NPH administered with steroid timing provides superior glycemic control compared to basal insulin analogs alone for dexamethasone-induced hyperglycemia 1.